Cytosorbents (CTSO) Work In Process (2023 - 2026)

Cytosorbents has reported Work In Process for 4 years, with the latest figure at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Work In Process rose 99.66% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 99.66% YoY), and the FY2025 full-year result was $1.0 million, up 101.59% from the prior year.
• Work In Process for Q1 2026 stood at $1.2 million, up from $1.0 million in the prior quarter.
• The five-year high for Work In Process was $1.2 million in Q1 2026, with the low at $503000.0 in Q4 2024.
• Historically, Work In Process has averaged $875775.3 across 4 years, with a median of $838871.0 in 2023.
• Annual changes were most pronounced in 2024 — Work In Process sank 40.04% — and 2025, when it jumped 101.59%.
• Cytosorbents' Work In Process stood at $838871.0 in 2023, then slumped by 40.04% to $503000.0 in 2024, then surged by 101.59% to $1.0 million in 2025, then rose by 22.39% to $1.2 million in 2026.
• The last three Work In Process figures came in at $1.2 million (Q1 2026), $1.0 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.